| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |